# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0002023658-24-000002
Filing Date
2024-11-12
Accepted
2024-11-12 16:02:19
Documents
72
Period of Report
2024-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | bcax-20240930.htm iXBRL | 10-Q | 2555955
2 | EX-10.7 | leaseagreement.htm | EX-10.7 | 193468
3 | EX-31.1 | exhibit311.htm | EX-31.1 | 10036
4 | EX-31.2 | exhibit312.htm | EX-31.2 | 9962
5 | EX-32.1 | exhibit321.htm | EX-32.1 | 7734
11 |  | image_1.jpg | GRAPHIC | 155
12 |  | image_3.jpg | GRAPHIC | 858
13 |  | image_4.jpg | GRAPHIC | 17161
14 |  | image_5.jpg | GRAPHIC | 140
15 |  | image_6.jpg | GRAPHIC | 18052
16 |  | image_7.jpg | GRAPHIC | 438117
| Complete submission text file | 0002023658-24-000002.txt |  | 7935777

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | bcax-20240930.xsd | EX-101.SCH | 39180
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | bcax-20240930_cal.xml | EX-101.CAL | 33680
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | bcax-20240930_def.xml | EX-101.DEF | 246456
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | bcax-20240930_lab.xml | EX-101.LAB | 537251
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | bcax-20240930_pre.xml | EX-101.PRE | 401806
75 | EXTRACTED XBRL INSTANCE DOCUMENT | bcax-20240930_htm.xml | XML | 520864

Mailing Address 245 MAIN STREET CAMBRIDGE MA 02142
Business Address 245 MAIN STREET CAMBRIDGE MA 02142 617-785-8308
Bicara Therapeutics Inc. (Filer) CIK: 0002023658 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42271 | Film No.: 241447816
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)